School of Medicine

School of Medicine researchers found that only about 58 percent of boys and about 45 percent of girls diagnosed with ADHD were receiving treatment. More medical news

The School of Medicine’s facilities and property will become entirely tobacco-free next spring in an effort to create a healthier environment.

The Division of Cardiothoracic Surgery recently switched from using paper files to a fully electronic medical record system to improve efficiency.

Two orthopaedic surgeons who have played a key role in the department’s growth were recognized with professorships.

Photo by Tim ParkerA lesson for cardiology fellows was held July 21-22 and had 35 fellows who came from as far away as West Virginia.

The Washington University Department of Orthopaedic Surgery and Barnes-Jewish Hospital have begun construction of a new, $13 million outpatient orthopaedic facility on property in a prime west St. Louis County location.

Peter Westervelt, M.D., Ph.D., has been named director of the bone marrow transplantation and leukemia section of the Division of Oncology at the School of Medicine. Westervelt, associate professor of medicine, succeeds John F. DiPersio, M.D., Ph.D., professor of medicine, in the position.

Daniel Stier / GQ, September 2006El Hombre vs. The BabeBaseball purists, especially those of Yankee allegiance, might argue that St. Louis Cardinals homerun-hitting superstar Albert Pujols is simply not in the same league as legendary New York Yankees slugger Babe Ruth. Science may never settle that argument, but researchers at Washington University in St. Louis can offer some sense of how Pujols stacks up to the Babe in terms of skills necessary to hit the long ball. Pujols visited WUSTL to take part in a series of lab tests similar to those conducted on Ruth in 1921.

Washington University researchers are tracking the source of a mysterious new tick-borne disease. They’re searching throughout the Midwest for ticks that carry the illness, with the hope of also identifying the animals responsible for spreading the disease. Called Southern tick-associated rash illness, the pathogen causes rashes and flulike symptoms.

A new St. Louis-based company will use a novel technology to rapidly screen thousands of drugs for their effectiveness against two of the biggest health threats in the United States — diabetes and cancer.